Question at position 52 When the FDA considers a new vaccine for approval their two main concerns are…Safety and efficacyFast approval and costProfit and lossNone of the aboveClear my selection

Question

BlackTom AI · Accepted Answer

The question asks about the two main concerns the FDA has when considering a new vaccine for approval. 
Option 1: 'Safety and efficacy' — This aligns with the core criteria the FDA uses to evaluate vaccines: they must be safe for recipients and effective in preventing or reducing disease. This is the standard framework for vaccine evaluation and regulatory approval. 
Option 2: 'Fast approval and cost' — While regulatory processes aim to be efficient, the FDA does not primarily base approval on speed or price; speed is contingent on meeting safety and efficacy standards, and cost is not a formal prerequisite for approval. 
Option 3: 'Profit and loss' — The FDA does not assess profitability or financial outcomes in its approval decision; scientific and public health considerations take precedence over business metrics. 
Option 4: 'None of the above' — This would imply neither safety nor efficacy is a concern, which contradicts the fundamental purpose of regulatory approval for vaccines. 
Thus, the reasoning for each option shows that the most aligned and appropriate concern is safety and efficacy, while the other options introduce factors not central to the FDA's primary evaluation criteria for vaccines.

Question at position 52 When the FDA considers a new vaccine for approval their two main concerns are…Safety and efficacyFast approval and costProfit and lossNone of the aboveClear my selection

View Explanation

Log in for full answers

Similar Questions

Before a new vaccine is approved for release on the market, a rigorous regulatory procedure to assess these steps should be undertaken:

In a consumer society, many adults channel creativity into buying things

Economic stress and unpredictable times have resulted in a booming industry for self-help products

People born without creativity never can develop it

A product has a selling price of $20, a contribution margin ratio of 40% and fixed cost of $120,000. To make a profit of $30,000. The number of units that must be sold is: Type the number without $ and a comma. Eg: 20000

Which of the following statement regarding cost is correct:

Under the assumptions used in cost-volume-profit analysis, as the activity increases:

The CVP and break-even analysis are supported by a range of important assumptions. Which of the following is not an assumption of the CVP:

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler